State Pharma Partners With Pakistan’s Hiranis Pharmaceuticals to Secure Essential Medicine Supply

State Pharmaceutical and Medical Supply Corporation (State Pharma) has signed a landmark distributorship agreement with Pakistan-based Hiranis Pharmaceuticals Private Limited to strengthen the Maldives' healthcare infrastructure. The agreement, signed on September 3, aims to create a more resilient system for delivering high-quality pharmaceutical products across the archipelago. By diversifying its international supplier network, the state-owned enterprise intends to streamline medical procurement and reduce the vulnerabilities associated with medicine shortages. This strategic partnership focuses on ensuring that citizens in every region, from the densely populated capital to the most remote islands, have seamless access to safe and essential medications. A core component of the collaboration involves enhancing logistical arrangements to maintain a sustainable and uninterrupted supply chain. Hiranis Pharmaceuticals brings extensive global experience to the partnership. The Pakistani manufacturer maintains a significant international footprint, exporting medical products to various markets across Asia, including Afghanistan and the Philippines. This established track record makes them a strategic ally for the Maldivian government as it seeks to fortify public health security. By establishing these reliable supply channels, State Pharma is moving toward a more sustainable procurement model. The initiative is expected to mitigate the risks of stockouts for critical medicines, ensuring that the national healthcare system can meet patient needs without interruption.